Rikkunshito and 5-HT2C receptor antagonist improve cisplatin-induced anorexia via hypothalamic ghrelin interaction

Regulatory Peptides

Volumn 161, Issue 1-3, 2010, Pages 97-105

  Yakabi, Koji ^a   Kurosawa, Susumu ^a   Tamai, Mitsuo ^b   Yuzurihara, Mitsutoshi ^b   Nahata, Miwa ^b   Ohno, Shino ^a   Ro, Shoki ^a   Kato, Shingo ^a   Aoyama, Toru ^a   Sakurada, Tomoya ^a   Takabayashi, Hidehiko ^a   Hattori, Tomohisa ^b  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Tsumura Research Institute   (Japan)

Author keywords

Cisplatin; Ghrelin; GHS R1a; Hypothalamus; RKT

Indexed keywords

6 CHLORO 5 METHYL 1 [[2 [(2 METHYL 3 PYRIDYL)OXY] 5 PYRIDYL]CARBAMOYL]INDOLINE; CISPLATIN; GHRELIN; GHRELIN RECEPTOR; GRANISETRON; HERBACEOUS AGENT; HESPERIDIN; ISOLIQUIRITIGENIN; MESSENGER RNA; ONDANSETRON; RIKKUNSHITO; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOREXIA; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; FOOD INTAKE; HORMONE ACTION; HYPOTHALAMUS; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; SIGNAL TRANSDUCTION;

ANIMALS; ANOREXIA; CISPLATIN; DRUGS, CHINESE HERBAL; EATING; GHRELIN; GRANISETRON; HYPOTHALAMUS; MALE; OLIGOPEPTIDES; ONDANSETRON; QUINOXALINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, SEROTONIN, 5-HT2C; RECEPTORS, GHRELIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH;

RATTUS;

EID: 77950338637     PISSN: 01670115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.regpep.2010.02.003     Document Type: Article

References (48)

1. Roila F., Garassio M., Fatigon S. New anti-emetic treatments. Ann Oncol 2007, 18(Supplement 9):43-47.
2. Poli-Bigelli S., Rodrigues-Pereira J., Carides A.D. Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America. Cancer 2003, 97:2931-2947.
3. Churm D., Andrew I.M., Holden K., Hildreth A.J., Hawkins C. A questionnaire study of the approach to the anorexia-cachexia syndrome in patients with cancer by staff in a district general hospital. Support Care Cancer 2009, 17:503-507.
4. Kojima M., Hosoda H., Date Y., Nakazato M., Matsuo H., Kangawa K. Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 1999, 402:656-660.
5. Asakawa A., Inui A., Kaga T., Katsuura G., Fujimiya M., Fujino M.A., Kasuga M. Antagonism of GHS-R1a reduces food intake and body weight gain in mice. Gut 2003, 52:947-952.
6. Banks W.A., Tschop M., Robinson S.M., Heiman M.L. Extent and direction of ghrelin transport across the blood-brain barrier is determined by its unique primary structure. J Pharmacol Exp Ther 2002, 302:822-827.
7. Mondal M.S., Date Y., Yamaguchi H., Toshinai K., Tsuruta T., Kangawa K., Nakazato M. Identification of ghrelin and its receptor in neurons of the rat arcuate nucleus. Regul Pept 2005, 126:55-59.
8. Asakawa A., Inui A., Fujimiya M., Sakamaki R., Shinfuku N., Ueta Y., Meguid M.M., Kasuga M. Stomach regulates energy balance via acylated ghrelin and desacyl ghrelin. Gut 2005, 54:18-24.
9. Shuto Y., Shibasaki T., Otagiri A., Otagiri A., Kuriyama H., Ohata H., Tamura H., Kamegai J., Sugihara H., Oikawa S., Wakabayashi I. Hypothalamic growth hormone secretagogue receptor regulates growth hormone secretion, feeding, and adiposity. J Clin Invest 2002, 109:1429-1436.
10. Tups A., Helwig M., Khorooshi R.M.H., Archer Z.A., Klingensport M., Mercer J.G. Circulating ghrelin levels and central GHS-R1a expression are elevated in response to food deprivation in a season mammal (Holdups sungorus). J Neuroendocrinol 2004, 16:922-928.
11. Nogueiras R., Tovar S., Mitchell S.E., Rayner D.V., Archer Z.A., Dieguez C., Williams L.M. Regulation of growth hormone secretagogue receptor gene expression in the arcurate nuclei of the rats by leptin and ghrelin. Diabetes 2004, 53:2552-2558.
12. Hirokawa R., Tachibana T., Katsumata N. Regulation of pituitary growth hormone-secretagogue and growth hormone-releasing hormone receptor RNA expression in young Dwarf rats. Endocr J 2000, 47:S53-S56. Suppl.
13. Takeda H., Sadakane C., Hattori T., Katsurada T., Ohkawara T., Nagai K., Asaka M. Rikkunshito, a herbal medicine, suppresses cisplatin-induced anorexia in rats via 5-HT 2 receptor antagonism. Gastroenterology 2008, 134:2004-2013.
14. Liu Y.L., Malik N.M., Sanger G.J., Andrews P.L. Ghrelin alleviates cancer chemotherapy-associated dyspepsia in rodents. Cancer Chemother Pharmacol 2006, 58:326-333.
15. Rudd J.A., Ngan M.P., Wai M.K., King A.G., Witherington J., Andrews P.L., Sanger G.J. Anti-emetic activity of ghrelin in ferrets exposed to the cytotoxic anti-cancer agent cisplatin. Neurosci Lett 2006, 392:79-83.
16. Liu Y., Hamaue N., Endo T., Hirafuji M., Minami M. 5-hydroxytryptamine(5-HT) concentrations in the hippocampus, the hypothalamus and the medulla oblongata related to cisplatin-induced PICA of rats. Res Commun Mol Pathol Pharmacol 2003, 113:97-113.
17. De Vry J., Schreiber R. Effects of selected serotonin 5-HT1 and 5-HT2 receptor agonists on feeding behavior: possible mechanisms of action. Neurosci Biobehav Rev 2000, 24:341-353.
18. Schreiber R., Selbach K., Asmussen M., Hesse D., De Vry J. Effects of serotonin 1/2 receptor agonists on dark-phase food and water intake in rats. Pharmacol Biochem Behav 2000, 67:291-305.
19. Lam D.D., Przydzial M.J., Ridley S.H., Yeo G.S.H., Rochford J.J., O'Rahilly S., Heisler L.K. Serotonin 5-HT2C receptor agonist promotes hypophagia via downstream activation of melanocortin 4 receptor. Endocrinology 2008, 149:1323-1328.
20. Tecott L.H. Serotonin and the orchestration of energy balance. Cell Metab 2007, 6:352-361.
21. Nonogaki K. Ghrelin and feedback system. Vitam Horm 2007, 77:150-170.
22. Fujitsuka N., Asakawa A., Hayashi M., Sameshima M., Amitani H., Kojima S., Fujimiya M., Inui A. Selective serotonin reuptake inhibitors modify physiological gastrointestinal motor activities via 5-HT2C receptor and acyl ghrelin. Biol Psychiatr 2009, 65(9):748-759. 1.
23. Takeda H., Muto S., Hattori T., Sadakane C., Tsuchiya K., Katsurada T., Ohkawara T., Oridate N., Asaka M. Rikkunshito ameliorates the aging-associated decrease in ghrelin receptor reactivity via phosphodiesterase III inhibition. Endocrinology 2010, 151(1):244-252.
24. Yagi M., Homma S., Kubota M., Iinuma Y., Kanada S., Kinoshita Y., Ohtaki M., Yamazaki S., Murata H. The herbal medicine Rikkunshi-to stimulates and coordinates the gastric myoelectric activity in post-operative dyspeptic children after gastrointestinal surgery. Pediatr Surg Int 2004, 19:760-765.
25. Tatsuta M., Iishi H. Effect of treatment with liu-jun-zi-tang(TJ-43) on gastric emptying and gastrointestinal symptoms in dyspeptic patients. Aliment Pharmacol Ther 1993, 7:459-462.
26. Miyoshi A., Yachi A., Masamune O., Ishikawa M. Clinical evaluation of the efficacy of TJ-43 Tsumura Rikkunshito on chronic gastritis with abdominal symptom-multicenter groups study in comparison with cisapride. Prog Med 1991, 11:1605-1631.
27. Suzuki H., Inadomi J.M., Hibi T. Japanese herbal medicine in functional gastrointestinal disorders. Neurogastroenterol Motil 2009, 21:688-696.
28. Tomono H., Ito Y., Watanabe T. Successful antiemetic treatment of Tsumura Rikkunshito extract granules for ethical use in addition to other antiemetic agents in neoadjuvant chemotherapy for an advanced breast cancer patient. Jpn J Cancer Chemother 2006, 33:1129-1131.
29. Hayashi A., Suzuki M., Sasamata M., Miyata K. Agonist diversity in 5-HT2C receptor-mediated weight control in rats. Psychopharmacology 2005, 178:241-249.
30. Pozzi L., Acconcia S., Ceglia I., Invernizzi R.W., Samani R. Stimulation of 5-hydroxytryptamine (5-HT2c) receptors in the ventrotegmental area inhibits stress-induced but not basal dopamine release in the rat prefrontal cortex. J Neurochem 2002, 82:93-100.
31. Popova N.K., Amstislavskaya T.G. Involvement of 5-HT1A and 5-H1B serotonergic receptor subtypes in sexual arousal in male mice. Psychoneuroendocrinology 2002, 27:609-618.
32. Shrestha Y.B., Wickwire K., Giraudo S. Effects of reducing hypothalamic ghrelin receptor gene expression on energy balance. Peptides 2009, 30:1336-1341.
33. Zigman J.M., Nakano Y., Coppari R., Balthasar N., Marcus J.N., Lee C.E., Jonesn J.E., Deysher A.E., Waxman A.R., White R.D., Williams T.D., Lachey J.L., Seeley R.J., Lowell B.B., Elmquist J.K. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest 2005, 115:3564-3572.
34. Sun Y., Wang P., Zheng H., Smith R.G. Ghrelin stimulation of growth hormone release and appetite is mediated through the growth hormone secretagogue receptor. Proc Natl Acad Sci USA 2004, 30:4679-4684.
35. Verhulst P.J., De Smet B., Saels I., Thijs T., Ver Donck L., Moechars D., Peeters T.L., Depoortere I. Role of ghrelin in the relationship between hyperphagia and accelerated gastric emptying in diabetic mice. Gastroenterolgy 2008, 135:1267-1276.
36. Nonogaki K., Kaji T., Ohba Y., Sumii M., Wakameda M., Tamari T. Serotonin 5-HT2C receptor-independent expression of hypothalamic NOR1, a novel modulator of food intake and energy balance, in mice. Biochem Biophys Res Commun 2009, 386:311-315.
37. Harrold J.A., Dovey T., Cai X.-J., Halford J.C.G., Pinkney J. Autoradiographic analysis of ghrelin receptors in the rat hypothalamus. Brain Res 2008, 1196:59-64.
38. Kennett G.A., Wood M.D., Bright F., Trail B., Riley G., Holland V., Avenell K.Y., Stean T., Upton N., Bromidge S., Forbes I.T., Brown A.M., Middelmiss D.N., Blackburn T.P. SB242084, a selective and brain penetrant 5-HT2C receptor antagonist. Neuropharmacology 1997, 36:609-620.
39. Nonogaki K., Ohba Y., Wakameda M., Tamari T. Fluvoxamine exerts anorexic effect in 5-HT2C receptor mutant mice with heterozygous mutation of beta-endorphin gene. Int J Neuropsychopharmacol 2009, 12:547-552.
40. Malik N.M., Moore G.B.T., Kaur R., Liu Y.L., Wood S.L., Morrow R.W., Sanger G.J., Andrews P.L. Adaptive upregulation of gastric and hypothalamic GHS-R1as and increased plasma ghrelin in a model of cancer chemotherapy-induced dyspepsia. Regul Pept 2008, 148:33-38.
41. Nonogaki K. New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000, 43:533-549.
42. Dryden S., Wang Q., Frankishu H.M., Williams G. Differential effects of the 5-HT1B/2C receptor agonist mCPP and 5-HT1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake. Peptides 1996, 17:943-949.
43. Hansen M.J., Morris M.J. Evidence for an interaction between neuropeptide Y and the melanocortin-4 receptor on feeding in the rat. Neuropharmacology 2002, 42:792-797.
44. Kesterson R.A., Huszar D., Lynch C.A., Simerly R.B., Cone R.D. Induction of neuropeptide Y gene expression in the dorsal medial hypothalamic nucleus in two models of the agouti syndrome. Mol Endocrinol 1997, 11:630-637.
45. Bagrol I.D., Lu X.Y., Kaelin C.B., Day H.E., Ollmann M., Gan E.I., Akil H., Marsh G.S., Watson S.J. Anatomy of an endogenous antagonist: relationship between Agoti-related protein and proopiomelanocortin in the brain. J Neurosci 1999, 18:1-7.
46. Inui A., Asakawa A., Bowers C.Y., Mantovani G., Laviano A., Meguid M.M., Fujimiya M. Ghrelin, appetite, and gastric motility: the emerging role of the stomach as an endocrine organ. FASEB J 2004, 18:439-456.
47. Cruse C.R.Y., Smith R.G. The growth hormone secretagogue receptor. Vitam Horm 2007, 77:89-119.
48. G-nitro-l-arginine. J Pharmacol Sci 2005, 98:161-167.